Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 6 49-6, 2004, Pages

  Martin, Gary R ^a   Wallace, Laurie E ^a   Sigalet, David L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Glucagon like peptide 2; Intestinal adaptation; Nutrition; SGLT 1; Short bowel syndrome; Total parenteral nutrition

Indexed keywords

CARBOHYDRATE; CASPASE 3; COTRANSPORTER; GLUCAGON LIKE PEPTIDE 2; GLUCOSE TRANSPORTER 5; SODIUM GLUCOSE COTRANSPORTER 1; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, RAT; CASPASE; GLUCAGON LIKE PEPTIDE; GLUCOSE TRANSPORTER; MEMBRANE PROTEIN; PEPTIDE; RECOMBINANT PROTEIN; SLC5A1 PROTEIN, HUMAN; SLC5A1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; ENTERIC FEEDING; HYPERTROPHY; INTESTINE ADAPTATION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MALE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHORT BOWEL SYNDROME; SMALL INTESTINE RESECTION; TOTAL PARENTERAL NUTRITION; ADAPTATION; ANIMAL; CELL DIVISION; ENZYME ACTIVATION; HUMAN; ILEUM; INTESTINE; INTESTINE ABSORPTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; SPRAGUE DAWLEY RAT;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CASPASE 3; CASPASES; CELL DIVISION; ENZYME ACTIVATION; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; ILEUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; MALE; MEMBRANE GLYCOPROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; PARENTERAL NUTRITION, TOTAL; PEPTIDES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SHORT BOWEL SYNDROME; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 2642544222     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00509.2003     Document Type: Article

References (59)

1. Au A, Gupta A, Schembri P, and Cheeseman CI. Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochem J 367: 247-254, 2002.
2. Bjerknes M and Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98: 12497-12502, 2001.
3. Bourne DWA. Research Applications in Pharmacokinetics in Drug Discovery and Development. Classical Modeling, edited by Schoenwald RD Boca Raton, FL: CRC, 2002, sect. IV, chapt. 12.
4. Briones ER and Iber FL. Liver and bilary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention. J Am Coll Nutr 14: 219-228, 1995.
5. Brubaker PL, Izzo A, Hill M, and Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol Endocrinol Metab 272: E1050-E1058, 1997.
6. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gorbein J, Kopple JD, and Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 19: 453-460, 1995.
7. Burrin DG, Stoll B, Jiang R, Petersen Y, Elnif J, Buddington RK, Schmidt M, Holst JJ, Hartmann B, and Sangild PT. GLP-2 stimulates intestinal growth by suppressing proteolysis and apoptosis in parenterally fed premature piglets. Am J Physiol Gastrointest Liver Physiol 279: G1249-G1256, 2000.
8. Chance WT, Foley-Nelson T, Thomas I, and Balasubramaiam A. Prevention of parenteral nutrition-induced gut hypoplasia by co-infusion of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 273: G559-G563, 1997.
9. Chance WT, Sheriff S, Foley-Nelson T, and Balasubramaniam A. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: effects of glucagon-like peptide 2. Nutr Cancer 37: 215-222, 2000.
10. Cheeseman CI. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol Regul Integr Comp Physiol 273: R1965-R1971, 1997.
11. Cohn SM and Lieberman MW. The use of antibodies to 5-bromo-2′ -deoxyuridine for the isolation of DNA sequences containing excision-repair sites. J Biol Chem 259: 12456-12462, 1984.
12. Cohn SM, Schloemann S, Tessner T, Seibert K, and Stenson WF. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 99: 1367-1379, 1997.
13. Dahley EM, Guo Z, and Ney DM. Alterations in enterocyte proliferation and apoptosis accompany TPN-induced mucosal hypoplasia and IGF-I-induced hyperplasia in rats. J Nutr 132: 2010-2014, 2002.
14. Dowling R and Booth C. Structural and functional changes following small intestinal resection in the rat. Clin Sci (Colch) 32: 139-143, 1967.
15. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122: 531-544, 2002.
16. 2]glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 273: G1252-G1262, 1997.
17. Drucker DJ, Ehrlich P, Asa SL, and Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide-2. Proc Natl Acad Sci USA 93: 7911-7916, 1996.
18. Dyer J, Vayro S, King TP, and Shirazi-Beechey SP. Glucose sensing in the intestinal epithelium. Eur J Biochem 270: 3377-3388, 2003.
19. Ghatei MA, Goodlad RA, Taheri S, Brynes AE, Jordinson M, and Bloom SR. Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide 2 is a major mediator of intestinal epithelial proliferation in rats. Dig Dis Sci 46: 1255-1263, 2001.
20. Guan X, Stoll B, Lu X, Tappenden KA, Holst JJ, Hartmann B, and Burrin DG. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets. Gastroenterology 125: 136-147, 2003.
21. Hartmann B, Harr MB, Jeppesen PB, Wojdemann M, Deacon CF, Mortensen PB, and Holst JJ. In vivo and in vitro degradation of glucagon-like peptide-2 in humans. J Clin Endocrinol Metab 85: 2884-2888, 2000.
22. Hartmann B, Thulesen J, Hare KJ, Kissow H, Orskov C, Poulsen SS, and Holst JJ. Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regul Pept 105: 173-179, 2002.
23. Holst JJ. Gut hormones as pharmaceuticals: from enteroglucagon to GLP-1 and GLP-2. Regul Pept 93: 45-51, 2000.
24. Kee AJ and Smith RC. The effect of the rate and route of delivery on total body and organ composition in rats. Nutrition 12: 180-188, 1996.
25. Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, Flyvberg A, Holst JJ, and Laurberg S. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol 281: G779-G785, 2001.
26. Lowry OH, Rosebrough NJ, and Fair AL. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
27. Martin GR, Meddings JB, and Sigalet DL. 3-0 Methylglucose absorption in vivo correlates with nutrient absorption and intestinal surface area in experimental short bowel syndrome. JPEN J Parenter Enteral Nutr 27: 65-70, 2003.
28. Martin GR, Wallace L, and Sigalet DL. Nutrient stimulated GLP-2 release and crypt cell production in experimental short bowel syndrome (Abstract). Gastroenterology 124: A596, 2003.
29. Martin GR, Wallace LE, Meddings JB, Sharkey KA, and Sigalet DL. GLP-2 stimulates intestinal adaptation in parenterally fed rats with short bowel syndrome: a potential role of the enteric nervous system in GLP-2 signaling. Neurogastroenterol Motil 15: 206, 2003.
30. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, and Drucker DJ. International union of pharmacology. XXXV. The glucagon receptor family. Pharmacol Exp Therap 55: 167-194, 2003.
31. Meddings JB and Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 114: 83-92, 1998.
32. Meehan JJ and Georgeson KE. Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome. J Pediatr Surg 32: 473-475, 1997.
33. Menge H, Hopert R, Alexopoulos T, and Riecken EO. Three-dimensional structure and cell kinetics at different sites of rat intestinal remnants during the early adaptive response to resection. Res Exp Med (Berl) 181: 77-94, 1982.
34. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang Z, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, and Crivici A. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96: 1569-1573, 1999.
35. O'Brien DP, Nelson LA, Huang FS, and Warner BW. Intestinal adaptation: structure, function, and regulation. Semin Pediatr Surg 10: 56-64, 2001.
36. Potten CS and Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110: 1001-1020, 1990.
37. Potten CS, Williamson S, Demchyshyn LL, and Booth CS. ALX-0600, a glucagon-like peptide-2 analogue, protects small intestinal stem cells from radiation damage. Gastroenterology W998, 2003.
38. Roberge JN and Brubaker PL. Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients. Endocrinology 128: 3169-3174, 1994.
39. Rocca AS and Brubaker PL. Role of the vagus nerve in mediating proximal nutrient induced glucagon-like peptide 1 secretion. Endocrinology 140: 1687-1696, 1999.
40. Scott RB, Kirk D, MacNaughton WK, and Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in the rat. Am J Physiol Gastrointest Liver Physiol 275: G911-G921, 1998.
41. Sherwood NM, Krueckl SL, and McRory JE. The origin and the function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagons superfamily. Endocr Rev 21: 619-670, 2000.
42. Sigalet DL. Short bowel syndrome in infants and children: an overview. Semin Pediatr Surg 10: 49-55, 2001.
43. Sigalet DL and Martin G. Hormonal therapy for short bowel syndrome. J Pediatr Surg 35: 360-363, 2000.
44. Sigalet DL, Martin GR, and Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg 5: 661-664, 2000.
45. Swartz-Basile DA, Rubin DC, and Levin MS. Vitamin A status modulates intestinal adaptation after partial small bowel resection. JPEN J Parenter Enteral Nutr 24: 81-88, 2000.
46. Swietlicki E, Iordanov H, Fritsch C, Yi L, Levin MS, and Rubin DC. Growth factor regulation of PC4/TIS7, an immediate early gene expressed during gut adaptation after resection. JPEN J Parenter Enteral Nutr 27: 123-131, 2003.
47. Tappenden KA, Bartholome AL, Demchyshyn LL, Lopansri J, and Sanguinetti E. ALX-0600, a glucagon-like peptide-2 (GLP-2) analog, enhances intestinal structure and function in patients with short bowel syndrome (SBS).
48. Tappenden KA, Thomson ABR, Wild GE, and McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology 112: 792-802, 1997.
49. Topstad D, Martin G, and Sigalet D. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. J Pediatr Surg 36: 750-754.
50. Tsai CH, Hill M, Asa SL, Brubaker PL, and Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol Endocrinol Metab 273: E77-E84, 1997.
51. Vanderhoof JA and Langnas AN. Short bowel syndrome in children and adults. Gastroenterology 113: 1767-1778, 1997.
52. Vanderhoof JA. Short bowel syndrome in children and intestinal transplantation. Pediatr Clin North Am 43: 533-550, 1996.
53. Vanderhoof JA, Langnas AN, Pinch LW, Thompson JS, and Kuafmann SS. Invited review: short bowel sybdrome. J Pediatr Gastroenterol Nutr 14: 359-370, 1992.
54. Velaquez E, Ruiz-Albusac JM, and Blazquez E. Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes. Eur J Biochem 270: 3001-3009, 2003.
55. Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, and Brubaker PL. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144: 4385-4392, 2003.
56. Williamson RC. Intestinal adaptation I and II. N Engl J Med 298: 1393-1450, 1978.
57. Xiao Q, Boushey RP, Drucker DJ, and Brubaker PL. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117: 99-105, 1999.
58. Yusta B, Boushey RP, and Drucker DJ. The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway. J Biol Chem 275: 35345-35352, 2000.
59. Yusta B, Huang L, Munroe D, Wolffe G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, and Drucker DJ. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119: 744-755, 2000.